MY008211A Tablet

MY008211A · Wuhan Createrna Science and Technology Co., Ltd

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MY008211A Tablet, covering 2024-08-09 to 2024-08-09. Get the full timeline:

Most recent: Clinical Trial Update: To Evaluate the Effect of Single Oral Dose of MY008211A Tablets on QTc Interval in Healthy Subjects [Phase 1]